Work

Figure S3 from Localized Treatment with Oncolytic Adenovirus Delta-24-RGDOX Induces Systemic Immunity against Disseminated Subcutaneous and Intracranial Melanomas

Year: 2023

Type: other

Abstract: A, Quantification of the tumor bioluminescence in the mice from the indicated treatment groups. D24-RGDOX: Delta-24-RGDOX. B, Waterfall plots showing tumor burden change from baseline in mice of indicated treatment groups base on the bioluminescence from the tumor. Baseline time point: Day 8 for s.c. tumor, Day 15 for i.c. tumor. Evaluation time point: Day 57 or the last time point before euthanasia.

DOI: 10.1158/1078-0432.22471637

Authors: Hong Jiang, Dong Ho Shin, Teresa T. Nguyen, Juan Fueyo, Xuejun Fan, Verlene Henry, Caroline C. Carrillo, Yanhua Yi, Marta M. Alonso, Tiara L. Collier, Ying Yuan, Frederick F. Lang, Candelaria Gomez-Manzano

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362406597

Cites:

Cited by:

Related to: 10